Rosenblatt raised the firm's price target on Adtran to $20 from $16 and keeps a Buy rating on the shares. The firm views the company's Q1 report as solid. The Broadband Equity, Access, and Deployment program and Adtran's new products should help the company's 2027, the analyst tells investors in a research note.